Tracie Oliver
Corporate Officer/Principal at ARROWHEAD PHARMACEUTICALS, INC.
Net worth: 4 M $ as of 2024-03-30
Profile
Tracie Oliver is the Chief Commercial Officer at Arrowhead Pharmaceuticals, Inc. She previously worked as the Head-Ortho Biotech Nephrology Business Unit at Johnson & Johnson.
She was also the Global Head-New Product Planning & Device Strategy at Shire Pharmaceuticals, Inc. from 2016 to 2017.
Ms. Oliver has an undergraduate and graduate degree from Queen's University and an MBA from The Schulich School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-04 | 136,501 ( 0.11% ) | 4 M $ | 2024-03-30 |
Tracie Oliver active positions
| Companies | Position | Start |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2022-05-31 |
Former positions of Tracie Oliver
| Companies | Position | End |
|---|---|---|
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | 2017-02-28 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Training of Tracie Oliver
| Queen's University | Graduate Degree |
| The Schulich School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
- Stock Market
- Insiders
- Tracie Oliver